...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Peripheral blood mononuclear cell responses from type 1 diabetic patients and subjects at-risk for type 1 diabetes to human fetal pancreatic tissue proteins.
【24h】

Peripheral blood mononuclear cell responses from type 1 diabetic patients and subjects at-risk for type 1 diabetes to human fetal pancreatic tissue proteins.

机译:1型糖尿病患者和1型糖尿病高危受试者对人胎儿胰腺组织蛋白的外周血单核细胞反应。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Fetal pancreatic tissue has been suggested to be less immunogenic than adult islets. Thus, transplantation of human fetal pancreatic tissue as treatment for type 1 diabetes has been gaining interest. To investigate this question, we tested the peripheral blood mononuclear cell (PBMC) responses from different subject populations to human adult islet proteins (AIP) versus human fetal pancreatic proteins (FPP). METHODS: PBMC responses to FPP and AIP from normal controls (n=14), newly diagnosed type 1 diabetes patients (n=5), long-term type 1 diabetes patients (n=9), and subjects at-risk for development of type 1 diabetes (n=3) were studied. RESULTS: We observed that normal controls demonstrated PBMC reactivity to 0-3 molecular weight regions (mwr) for both the AIP (mean+/-SD, 0.8+/-1.1) and the FPP (0.6+/-0.7). In contrast, newly diagnosed type 1 diabetic patients (<1 year) demonstrated PBMC responses to 9-16 mwr for the AIP (12.8+/-2.5) and 0-14 mwr for the FPP (6.8+/-5.0). The PBMCs from long-term type 1 diabetes patients (> 3 years) were responsive to 2-11 mwr for AIP (6.0+/-2.8) and 0-11 mwr for FPP (4.9+/-4.0). Three nondiabetic ICA positive subjects at-risk for development of type 1 diabetes demonstrated positive PBMC reactivity to 9-18 mwr for the AIP (12.7+/-3.9) and 4-18 mwr for the FPP (10.0+/-5.9). CONCLUSIONS: We conclude that human fetal pancreatic proteins are not significantly less stimulatory than human adult islet proteins to PBMCs of subjects with or at risk for type 1 diabetes.
机译:背景:胎儿胰腺组织的免疫原性低于成年胰岛。因此,人类胎儿胰腺组织的移植作为1型糖尿病的治疗已引起人们的兴趣。为了调查这个问题,我们测试了不同受试者群体对人成年胰岛蛋白(AIP)和人胎胰蛋白(FPP)的外周血单核细胞(PBMC)反应。方法:PBMC对正常对照组(n = 14),新诊断的1型糖尿病患者(n = 5),长期1型糖尿病患者(n = 9)和发展为高危受试者的FPP和AIP的反应研究了1型糖尿病(n = 3)。结果:我们观察到,正常对照对AIP(平均值+/- SD,0.8 +/- 1.1)和FPP(0.6 +/- 0.7)均显示出PBMC对0-3分子量区域(mwr)的反应性。相反,新诊断的1型糖尿病患者(<1年)表现出PBMC对AIP的反应为9-16 mwr(12.8 +/- 2.5),对于FPP为0-14 mcwr(6.8 +/- 5.0)。来自长期1型糖尿病患者(> 3年)的PBMC对AIP的2-11 mwr(6.0 +/- 2.8)和对于FPP的0-11 mwr(4.9 +/- 4.0)有反应。三名患有1型糖尿病风险的非糖尿病ICA阳性受试者表现出AIP(12.7 +/- 3.9)和9-18 FRP(10.0 +/- 5.9)分别对9-18 mwr和4-18 mwr的PBMC阳性。结论:我们得出结论,人类胎儿胰腺蛋白对人1型糖尿病或有患病风险的PBMC的刺激作用不比成人胰岛蛋白显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号